VolitionRx raises $1.21M in registered direct offering; insiders buy stock

VOLITIONRX LTD

156,250 shares sold to directors/officers at $0.64/share; 1,734,375 shares + warrants at $0.64/unit.
Gross proceeds of $1.21M; potential additional $1.3M from warrants at $0.768/share.
Warrants exercisable for 5 years from Aug 2025; insiders receive no warrants.
No placement agent; offering expected to close Aug 5, 2025.
Net proceeds for R&D, product development, clinical studies, working capital, and potential M&A.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.